M&T Bank Corp United Therapeutics Corp Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, M&T Bank Corp holds 3,135 shares of UTHR stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,135

Previous 3,135 -0.0%

Holding current value

$1.11 Million

Previous $1.12 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$311.04 - $363.55 $18,351 - $21,449	-59 Reduced 1.85%	3,135 $1.12 Million
Q2 2024 Jul 31, 2024	SELL	$228.26 - $319.04 $3,880 - $5,423	-17 Reduced 0.53%	3,194 $1.02 Million
Q1 2024 May 07, 2024	SELL	$210.76 - $249.51 $122,662 - $145,214	-582 Reduced 15.34%	3,211 $737,000
Q4 2023 Feb 06, 2024	BUY	$214.88 - $256.94 $3,652 - $4,367	17 Added 0.45%	3,793 $834,000
Q3 2023 Nov 02, 2023	SELL	$211.82 - $248.24 $11,226 - $13,156	-53 Reduced 1.38%	3,776 $852,000
Q2 2023 Aug 09, 2023	BUY	$205.19 - $232.99 $13,542 - $15,377	66 Added 1.75%	3,829 $845,000
Q1 2023 May 11, 2023	BUY	$212.99 - $276.17 $21,299 - $27,617	100 Added 2.73%	3,763 $842,000
Q4 2022 Feb 13, 2023	BUY	$205.95 - $280.43 $274,943 - $374,374	1,335 Added 57.37%	3,662 $1.02 Million
Q4 2022 Feb 13, 2023	BUY	$205.95 - $280.43 $205 - $280	1 Added 0.03%	3,663 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $302,917 - $363,813	-1,490 Reduced 39.04%	2,327 $347,000
Q2 2022 Aug 05, 2022	BUY	$174.81 - $241.14 $435,102 - $600,197	2,489 Added 187.42%	3,817 $402,000
Q1 2022 May 09, 2022	BUY	$166.16 - $213.96 $9,138 - $11,767	55 Added 4.32%	1,328 $239,000
Q4 2021 Feb 07, 2022	BUY	$184.32 - $216.08 $4,976 - $5,834	27 Added 2.17%	1,273 $274,000
Q2 2021 Aug 13, 2021	SELL	$170.47 - $211.93 $852 - $1,059	-5 Reduced 0.4%	1,246 $223,000
Q1 2021 May 06, 2021	SELL	$153.94 - $174.85 $22,013 - $25,003	-143 Reduced 10.26%	1,251 $209,000
Q4 2020 Feb 12, 2021	BUY	$101.87 - $151.79 $142,006 - $211,595	1,394 New	1,394 $212,000
Q3 2020 Nov 06, 2020	SELL	$99.9 - $121.13 $196,003 - $237,657	-1,962 Closed	0 $0
Q2 2020 Jul 29, 2020	SELL	$92.74 - $125.82 $23,648 - $32,084	-255 Reduced 11.5%	1,962 $238,000
Q1 2020 May 14, 2020	SELL	$79.39 - $115.35 $28,342 - $41,179	-357 Reduced 13.87%	2,217 $210,000
Q4 2019 Feb 07, 2020	BUY	$78.31 - $95.34 $201,569 - $245,405	2,574 New	2,574 $227,000
Q2 2019 Aug 12, 2019	SELL	$76.06 - $120.81 $155,542 - $247,056	-2,045 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $9,964 - $11,796	-93 Reduced 4.35%	2,045 $240,000
Q4 2018 Feb 01, 2019	BUY	$101.4 - $128.73 $4,056 - $5,149	40 Added 1.91%	2,138 $233,000
Q3 2018 Nov 09, 2018	BUY	$113.81 - $129.46 $7,966 - $9,062	70 Added 3.45%	2,098 $269,000
Q2 2018 Aug 10, 2018	BUY	$101.14 - $118.31 $1,415 - $1,656	14 Added 0.7%	2,028 $231,000
Q1 2018 May 04, 2018	SELL	$107.21 - $151.94 $24,015 - $34,034	-224 Reduced 10.01%	2,014 $225,000
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $2,406 - $2,873	21 Added 0.95%	2,238 $262,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,217	2,217 $288,000

Others Institutions Holding UTHR

# of Institutions

673

Shares Held

42.2M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account